Fund BasicsSee More
- Fund Family Invesco
- Assets Under Management 54,903,600
- Shares Outstanding, K 2,020
- 60-Month Beta 0.00
- Price/Earnings ttm 28.45
- Annual Dividend & Yield N/A (0.00%)
- Most Recent Dividend N/A on N/A
- Management Fee 0.00%
|Period||Period Low||Period High||Performance|
| || |
+0.52 (+1.95%)since 08/17/21
| || |
+2.02 (+8.03%)since 06/17/21
Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.
Moderna, known for its success in the COVID-19 vaccine, has entered the big league with its addition to the S&P 500 Index.
Dow has Worst Week of the Year on Rate Hike Fears
Biotech stocks are rallying this month; can the trend continue?
/PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global asset manager, announced today the launch of two new exchange-traded funds (ETFs) that capture timely technology themes – biotechnology and...
|3rd Resistance Point||27.75|
|2nd Resistance Point||27.47|
|1st Resistance Point||27.32|
|1st Support Level||26.89|
|2nd Support Level||26.61|
|3rd Support Level||26.46|